D'ALESSIO, ANTONIO
 Distribuzione geografica
Continente #
AS - Asia 347
NA - Nord America 233
EU - Europa 173
SA - Sud America 38
AF - Africa 34
Totale 825
Nazione #
US - Stati Uniti d'America 211
SG - Singapore 142
HK - Hong Kong 79
CN - Cina 42
RU - Federazione Russa 41
BJ - Benin 31
BR - Brasile 27
DE - Germania 25
IT - Italia 25
VN - Vietnam 23
AT - Austria 19
KR - Corea 18
GB - Regno Unito 17
IN - India 13
CA - Canada 11
MX - Messico 10
BD - Bangladesh 8
FR - Francia 8
PL - Polonia 8
AR - Argentina 7
ES - Italia 6
LT - Lituania 5
NL - Olanda 5
FI - Finlandia 4
JP - Giappone 4
TR - Turchia 4
UA - Ucraina 4
IQ - Iraq 3
PH - Filippine 3
SE - Svezia 3
CH - Svizzera 2
EC - Ecuador 2
BE - Belgio 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ID - Indonesia 1
KH - Cambogia 1
LB - Libano 1
MA - Marocco 1
MY - Malesia 1
NP - Nepal 1
PY - Paraguay 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 825
Città #
Hong Kong 77
Singapore 46
Ashburn 41
Beijing 31
Cotonou 31
Los Angeles 21
Seoul 18
Brooklyn 11
Buffalo 11
Moscow 9
New York 8
Vienna 8
Falkenstein 7
Novara 7
Warsaw 7
Assago 6
Hanoi 6
Nuremberg 6
Dallas 5
São Paulo 5
Toronto 5
Boston 4
Chennai 4
Denver 4
Frankfurt am Main 4
Ho Chi Minh City 4
London 4
Mexico City 4
Mumbai 4
Orem 4
Poplar 4
Santa Clara 4
Tokyo 4
Ankara 3
Dhaka 3
Stockholm 3
Baie-D'Urfé 2
Bragança Paulista 2
Curitiba 2
Córdoba 2
Elk Grove Village 2
Genoa 2
Haiphong 2
Helsinki 2
Manila 2
Phoenix 2
Providence 2
Querétaro 2
Quito 2
Raleigh 2
Redondo Beach 2
Seattle 2
Sona 2
Thái Bình 2
Turku 2
Zurich 2
Ahmedabad 1
Amsterdam 1
América 1
Apodaca 1
Apucarana 1
Asunción 1
Atlanta 1
Baghdad 1
Bathgate 1
Bengaluru 1
Bexley 1
Bologna 1
Botucatu 1
Boulogne Sur Mer 1
Buenos Aires 1
Calgary 1
Campeche 1
Campinas 1
Can Tho 1
Caracas 1
Charleston 1
Chittagong 1
Cleveland 1
College Park 1
Concord 1
Coronel Suárez 1
Cotuí 1
Dakhla 1
Damascus 1
Dayton 1
Dublin 1
Florissant 1
Fort Worth 1
Ha Long 1
Hampton 1
Hangzhou 1
Harrogate 1
Helena 1
Hoffman 1
Honolulu 1
Huntington 1
Islington 1
Istanbul 1
Jacareí 1
Totale 507
Nome #
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 68
Immunotherapy vs Best Supportive Care for Patients with Hepatocellular Cancer with Child-Pugh B Dysfunction 44
New Scenarios in Liver Transplantation for Hepatocellular Carcinoma 44
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours 44
Single-cell RNA seq-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma 43
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis 43
Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis 41
Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events 40
A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma 39
The price and value of therapeutic synergy in liver cancer 38
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma 38
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study 37
ctDNA: A Gateway for Personalized Risk Stratification in Surgically Resectable Hepatocellular Cancer 37
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study 37
Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparison 36
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study 36
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma 35
Immunotherapy Benefit Over Best Supportive Care in Hepatocellular Cancer With Child-Pugh B Dysfunction-Reply 32
Immunotherapy at all stages of hepatocellular carcinoma 32
Diabetes and Immune Checkpoint Inhibitors—Response 32
Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma 30
The Hammersmith Score Optimises Patient Selection and Predicts for Overall Survival in Early-Phase Cancer Trial Participants Independent of Tumour Burden 17
Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis 16
Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence 1
Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study 1
Totale 861
Categoria #
all - tutte 3.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.880


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025400 5 0 5 2 4 7 45 106 98 37 13 78
2025/2026461 56 33 48 120 192 12 0 0 0 0 0 0
Totale 861